Related Experiment Videos
[Treating retinopathy of prematurity with laser diode photocoagulation]
Insights
Diode laser photocoagulation effectively treats retinopathy of prematurity (ROP) in its active stage. This safe procedure yielded favorable outcomes in over 80% of treated eyes, making it a preferred treatment for ROP.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Laser Surgery
Background:
- Retinopathy of prematurity (ROP) is a significant cause of visual impairment in premature infants.
- Active-stage ROP requires timely and effective intervention to prevent severe visual loss.
Purpose of the Study:
- To evaluate the efficacy and safety of diode laser photocoagulation for active stage 3 ROP.
- To review current treatment strategies for active ROP.
Main Methods:
- Retrospective analysis of 96 infants (185 eyes) treated with diode laser retinal photocoagulation.
- Treatment targeted active stage 3 ROP between 1996 and 2000.
Main Results:
- A favorable structural outcome was achieved in 83.8% of treated eyes.
- Complications were minimal, with no serious adverse events reported post-treatment.
- Disease progression occurred in a minority of cases, leading to outcomes like retinal folds or detachment.
Conclusions:
- Diode laser photocoagulation is a safe and effective treatment for active stage 3 ROP.
- The procedure is particularly beneficial for ROP involving zones 1 and 2.
- Diode laser photocoagulation is the established preferred treatment for active stage 3 ROP in the study setting.
Aim:
The purpose of the study was to assess the outcomes of the diode laser in the treatment of retinopathy of prematurity and to discuss the up-to-date possibilities of treating of active phase of this disease.
Material And Methods:
96 children (185 eyes) treated with diode laser retinal photocoagulation for active stage 3 of ROP in our department in years 1996-2000.
Results:
Favorable structural outcome was observed in 83.8% of treated eyes. In the remaining eyes the disease progressed despite of the treatment and falciform retinal fold (5.4%), partial retinal detachment (6.5%) and total retinal detachment (4.3%) developed. No serious complications were observed after the treatment.
Conclusions:
Diode laser retinal photocoagulation is a safe and effective procedure for treating active stage 3 of retinopathy of prematurity. It has been especially useful for treatment of changes in zone 1 and 2 of the disease. Diode laser photocoagulation is now the preferred method of treating active stage 3 of ROP in our department.